Kodak’s Health Group has a new head. On Feb.16, the company appointed Kevin J. Hobert president of the group and senior vice president of Eastman Kodak. He will report to Antonio M. Perez, Kodak’s president and COO.
Kodak's Health Group has a new head. On Feb.16, the company appointed Kevin J. Hobert president of the group and senior vice president of Eastman Kodak. He will report to Antonio M. Perez, Kodak's president and COO.
Hobert replaces Daniel Kerpelman, who is leaving the company to become CEO
of SGS Group, a publicly traded European firm. Kerpelman will assume his new duties April 11. SGS Group, founded in 1878, runs about 1000 offices and laboratories around the world specializing in inspection, verification, testing, and certification. Services are provided to a number of industries, including diagnostics.
Hobert previously served as general manager of Kodak's Digital Capture Systems and vice president of its Health Group. Under Hobert, Kodak's computed radiography business has attained the number two position worldwide, according to the company. Hobert also recently ushered Kodak's mammography CAD system through the FDA approval process.
Hobert joined Kodak in 2002 from GE Medical Systems, after 11 years in medical imaging. He was responsible for leading GEMS' global businesses addressing digital, analog and mobile radiography and multipurpose fluoroscopy. Hobert holds a bachelor of science in physics from the University of Wisconsin.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.